Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.890
+0.080 (2.10%)
Jun 10, 2026, 11:31 AM EDT - Market open
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $49.63 million as of June 10, 2026. Its market cap has increased by 39.88% in one year.
Market Cap
49.63M
Enterprise Value
42.35M
1-Year Change
39.88%
Ranking
Category
Stock Price
$3.89
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $49.63M, an increase of 63.64%. That is a compound annual growth rate of 8.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 48.61M | 43.44% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 50.12M |
| Immutep | 50.02M |
| Dogwood Therapeutics | 48.77M |
| Tevogen Bio Holdings | 48.74M |
| Mereo BioPharma Group | 48.68M |
| Estrella Immunopharma | 48.63M |
| Metagenomi Therapeutics | 48.56M |
| Veru Inc. | 48.15M |